Dr. Gerard Thomas Berry Sr., MD

Dr. Berry practices at Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut.

Dr. Berry's NPI, 1932189255, was assigned on January 20, 2006. Dr. Berry graduated from Sidney Kimmel Medical College in 1975. Dr. Berry holds Massachusetts license 230307.

Dr. Berry's primary practice is Yale New Haven Psychiatric Hospital (York St), at 20 York Street, New Haven, CT 06510. The practice phone is (203) 688-5900.

Dr. Berry's primary practice is Yale New Haven Psychiatric Hospital (York St) in New Haven, Connecticut. Dr. Berry is also affiliated with Boston Children's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Berry to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berry practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical biochemical genetics is Dr. Berry's primary specialty in the NPI Registry, under taxonomy code 207SG0202X. Dr. Berry is board certified in clinical biochemical genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Berry's licenses on file in 5 states: Massachusetts, Pennsylvania, District of Columbia, Maryland and New Jersey.

CMS data shows 15 Medicare services from Dr. Berry across 1 procedure code in 2019, all of them office visits. Medicare paid $1,876 for them. Every service was in an office.

Across all payers, Dmand AI patient panel data puts Dr. Berry's median patient age at 84, with 57% women.

In 2021, Dr. Berry wrote 12 Medicare Part D claims. They cover 1 drug, with $698,866 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

Dmand AI links 181 papers to Dr. Berry, published from 2001 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Galactosemias, Galactose and UTP-Hexose-1-Phosphate Uridylyltransferase. Dr. Berry has published most often in Mol Genet Metab. Dr. Berry's most frequent co-authors are Paige B. Kaplan, MD, Lance Harrington Rodan, MD and Harvey Louis Levy, MD.

Dmand AI links Dr. Berry to 4 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Methylmalonic acidemia, Carbamoyl-Phosphate Synthase I Deficiency Disease and Congenital Disorders of Glycosylation. Mendel Tuchman sponsors the most, 2.

CMS Open Payments shows 40 general payments to Dr. Berry from 5 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 36% of the total. BioMarin Pharmaceutical Inc. paid the most, $4,778.

Dmand AI lists 1 award for Dr. Berry, most recently Sidney Kimmel Medical College at Thomas Jefferson University Alumni Achievement Award in 2016.

Dr. Berry graduated from Sidney Kimmel Medical College in 1975. Dr. Berry is a member of SIMD.

Dr. Berry is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.